NEDD8 and cancer: Intensive studies have proven that NEDD8 and enzymes of neddylation pathway (e.g. NAE1/UBA3, UBE2M/UBE2F and NEDD8 E3 ligases) are often overexpressed in multiple human cancers, which is associated with disease progression and predicts poor patient survival [20–27].